Human fertilisation and embryology bill.
Explore the source record for details and available documents.
Confidentiality↗
SEARCH · PubMed Health
Results for “Human Fertilisation and Embryology Bill”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Human fertilisation and embryology bill goes to report stage.
Explore the source record for details and available documents.
Confidentiality↗
Embryo bill could allow children to trace biological fathers.
Explore the source record for details and available documents.
Child↗
On the winds of fortune.
Explore the source record for details and available documents.
Embryo Research↗
Lords' vote saves supply of research embryos.
Explore the source record for details and available documents.
Embryo Research↗
Parliament gives overwhelming approval to embryo research.
Explore the source record for details and available documents.
Embryo Research↗
The embryo debate.
Explore the source record for details and available documents.
Beginning of Human Life↗
Stem cell technologies: regulation, patents and problems.
Human embryonic stem cell research promises to deliver in the future a whole range of therapeutic treatments, but currently governments in different jurisdictions must try to regulate this burgeoning area. Part of the problem has been, and continues to be, polarised community opinion on the use of human embryonic stem cells for research. This article compares the approaches of the Australian, United Kingdom and United States governments in regulating human embryonic stem cell research. To date, these governments have approached the issue through implementing legislation or policy to control research. Similarly, the three jurisdictions have viewed the patentability of human embryonic stem cell technologies in their own ways with different policies being adopted by the three patent offices. This article examines these different approaches and discusses the inevitable concerns that have been raised due to the lack of a universal approach in relation to the regulation of research; the patenting of stem cell technologies; and the effects patents granted are having on further human embryonic stem cell research.
Australia↗
Assisted conception and clinical practice: whose freedom is it?
Explore the source record for details and available documents.
Female↗
Parliamentary cultures and human embryos: the Dutch and British debates compared.
Twenty years ago, the technology of in vitro fertilization created a new artefact: the human embryo outside the woman's body. In many countries, political debates developed around the artefact. One of the central questions in these debates is whether it is permissible to use human embryos in research and, if so, under what conditions. To date, no uniform answer to this question has been given by the governments and parliaments of the different nation states. This highlights the importance of national cultures and local dynamics in the process of crafting the space for human embryo research. In this paper I approach the issue of the national context by comparing the Dutch and British parliamentary debates on human embryos. Though some arguments used in both debates were similar, the outcomes were very different. In the UK, the Human Fertilisation and Embryology Act was passed in 1990. In the Netherlands, several bills on human embryos have been drafted, but each of them was withdrawn from the proceedings before reaching Parliament. To understand the processes which led to these different outcomes, I scrutinize the roles in the Netherlands of the political parties, of the scientists' lobby and of women speakers, and compare them with the findings of the UK debate. I also reflect upon the role played by gender in these two culturally different political contexts.
Bioethics↗